Evidence map›Paper›PMID 41289387›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Human coronavirus 3CL protease manipulates host protein STIM1 to facilitate immune evasion.

Yoon Young Lee, Ah Reum Lee, Seongkyung Seo, Uni Park, Taehun Kim, Sang Kwon Lee, Hyeongsun Jeong, Su Ji Jeong, Yeong Cheon Kweon, Go Eun Park and 8 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yoon Young Lee *Department of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.ORCID 0000-0001-6328-490X
Ah Reum Lee *Department of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.ORCID 0000-0002-2028-2856
Seongkyung Seo *Department of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.ORCID 0000-0002-3277-6140
Uni ParkDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Taehun KimDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.ORCID 0009-0009-7283-9749
Sang Kwon LeeDepartment of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
Hyeongsun JeongDepartment of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
Su Ji JeongDepartment of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
Yeong Cheon KweonDepartment of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.ORCID 0000-0003-3659-6910
Go Eun ParkDepartment of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
Min Ji KimDepartment of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
Byung-Gyu KimCenter for Genomic Integrity, Institute for Basic Science, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
Taejoon KwonDepartment of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.ORCID 0000-0002-9794-6112
Nam-Hyuk ChoDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Hyug Moo KwonDepartment of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.ORCID 0000-0003-3244-2025
Kyungjae MyungDepartment of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
Sang Min LeeDepartment of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.ORCID 0009-0004-1182-5320
Chan Young ParkDepartment of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.ORCID 0000-0002-5183-3665

Funding

Institute for Basic Science (IBS) IBS-R022-D1National Research Foundation of Korea (NRF) 2021M3A9I2080490National Research Foundation of Korea (NRF) RS-2018-NR031009National Research Foundation of Korea (NRF) RS-2024-00359310National Research Foundation of Korea (NRF) RS-2024-00451519Regenerative medicine acceleration foundation (RMAF) RS-2023-KH141086
6 · The paper itself

Abstract

Coronaviruses rely on intricate interactions with host proteins to create an environment conducive to their replication and survival. The 3CL protease of coronavirus acts as a key mediator, serving a dual role in cleaving viral polyproteins to produce essential components for replication and targeting host proteins to disrupt regulatory pathways and suppress immune defenses. However, the mechanisms by which 3CL protease manipulates host proteins remain poorly understood. Here, we identify STIM1, a substrate of the 3CL protease, as a dual immune suppressor. Cleavage at the Q496 residue generates two stable products, N-terminal (NT) and C-terminal (CT) fragments, which acquire de novo immunomodulatory functions. NT suppresses MAVS aggregation and MAVS-TRAF2-TBK1 signalosome formation, while CT attenuates IKKα-induced p65 phosphorylation and nuclear translocation by interacting with HSP70. Collectively, these dual modules simultaneously lead to the suppression of IFN-β production and the weakening of antiviral defenses. These findings reveal a distinct function of STIM1 and delineate a strategy employed by coronaviruses to modulate host immunity, offering insights into viral pathogenesis and potential avenues for therapeutic intervention.

Indexed as

Coronavirus 3C ProteasesImmune EvasionNeoplasm ProteinsSARS-CoV-2Stromal Interaction Molecule 1HEK293 CellsHost-Pathogen InteractionsHumansPhosphorylationSignal TransductionCoronavirus 3C ProteasesNeoplasm ProteinsSTIM1 protein, humanStromal Interaction Molecule 13CL proteasecoronavirusIFN-βSTIM1

Identifiers

PMID41289387
PMCPMC12685117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.